Poliovirus types 1 and 3 — Drug Target
All drugs that target Poliovirus types 1 and 3 — marketed and clinical-stage. Includes 3 drug classes acting on this target.
Drug classes
Live attenuated vaccine · Live attenuated viral vaccine · vaccine
Marketed (3)
- bOPV (two dose) · Centers for Disease Control and Prevention · Live attenuated vaccine · Immunology / Infectious Disease
bOPV (bivalent oral polio vaccine) stimulates the immune system to produce antibodies against poliovirus types 1 and 3, providing protection against poliomyelitis. - bOPV 1,3 · Institute of Medical Biology, Chinese Academy of Medical Sciences · Live attenuated viral vaccine · Immunology / Infectious Disease
bOPV 1,3 is a bivalent oral polio vaccine containing live attenuated poliovirus types 1 and 3 that induces mucosal and systemic immunity against poliomyelitis. - bOPV (three dose) · Centers for Disease Control and Prevention · vaccine · Immunology / Infectious Disease
bOPV (bivalent oral polio vaccine) stimulates the immune system to produce antibodies against poliovirus types 1 and 3, providing protection against poliomyelitis.